Update March 23, 2020:
BioLife takes the safety of its donors - and donation process - very seriously. In an attempt to minimize any COVID-19 risk, we are committed to limiting opportunities for close contact and are asking donors to attempt 6 feet of distance between yourselves.
In Center, you will notice that we are assisting this request by increasing separations between EDQ stations, Medical History booths, donor lines and donor beds.
Coronavirus (COVID-19): Latest Update from BioLife Plasma Centers
Our donor and staff safety are always our top priority at BioLife Plasma. We understand you may have questions and concerns regarding the novel coronavirus (COVID-19).
As part of our commitment to the health and well-being of our staff, donors and our communities, we are carefully monitoring this evolving situation. BioLife Plasma and our parent company Takeda Pharmaceuticals continue to monitor the situation closely through information shared by the Centers for Disease Control and Prevention (CDC) and other government and health agencies around the world in order to keep everyone safe and well informed.
Based on current guidance, BioLife Plasma will continue to welcome donors into our collection centers and operate according to normal business hours. Every day, thousands of people with rare and chronic diseases rely on the therapies produced from the plasma we collect.
To give you peace of mind, we want to remind you that BioLife Plasma has set the standard for cleanliness in the industry. We have the following health and safety protocols in place.
March 18, 2020 Update
In addition to the health and safety protocols noted below in the gray box, the following changes are being made within our centers immediately: